Literature DB >> 12955252

[Malignant schwannoma of the trachea].

K Neumann1, S Amm, U Krause, A Berghaus.   

Abstract

Malignant schwannoma of the trachea is a rarity among the infrequent neurogenic tumours of the cervical region. Only individual cases have been described in the literature to date. A 30-year-old patient came to us with acute dyspnoea. A bronchoscopy showed a polypoid-stemmed tumour, which was removed using a loop. Histologically, it was a malignant neurogenic tumour of a low-grade schwannoma nature. A tracheal segment resection was carried out to remove the tumour completely. Six years after the operation, the patient was still recurrence-free. The prognosis depends on whether a high or low grade malignant schwannoma is present. The histological grading of the neurogenic peripheral neurilemmoma is made depending on a number of histological parameters and is often rather difficult. Specialists agree that only the radical surgical removal of the tumour might lead to patient's recovery. Adjuvant measures like chemo- or radiotherapy do not significantly prolong the life expectancy.

Entities:  

Mesh:

Year:  2003        PMID: 12955252     DOI: 10.1007/s00106-002-0800-z

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  10 in total

1.  Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases.

Authors:  B S Ducatman; B W Scheithauer; D G Piepgras; H M Reiman; D M Ilstrup
Journal:  Cancer       Date:  1986-05-15       Impact factor: 6.860

2.  Malignant schwannoma. A clinicopathologic study.

Authors:  B C Ghosh; L Ghosh; A G Huvos; J G Fortner
Journal:  Cancer       Date:  1973-01       Impact factor: 6.860

3.  Solitary malignant schwannoma.

Authors:  T K Das Gupta; R D Brasfield
Journal:  Ann Surg       Date:  1970-03       Impact factor: 12.969

4.  Survival in malignant schwannoma. An 18-year study.

Authors:  H R White
Journal:  Cancer       Date:  1971-03       Impact factor: 6.860

Review 5.  Schwannomas.

Authors:  S I Hajdu
Journal:  Mod Pathol       Date:  1995-01       Impact factor: 7.842

6.  Solitary cutaneous malignant schwannoma. Immunohistochemical and ultrastructural studies.

Authors:  A Kikuchi; M Akiyama; H Han-Yaku; H Shimizu; W Naka; T Nishikawa
Journal:  Am J Dermatopathol       Date:  1993-02       Impact factor: 1.533

7.  Malignant schwannoma--clinical characteristics, survival, and response to therapy.

Authors:  P P Sordillo; L Helson; S I Hajdu; G B Magill; C Kosloff; R B Golbey; E J Beattie
Journal:  Cancer       Date:  1981-05-15       Impact factor: 6.860

8.  Acute respiratory distress due to malignant schwannoma. A case report.

Authors:  M Melíkoğlu; S Karavelí; T Colak; T Gelen
Journal:  Eur J Pediatr Surg       Date:  1992-08       Impact factor: 2.191

9.  Treatment of extensive malignant schwannoma of the mandibular nerve.

Authors:  T Raveh; A R Neuman; A Weinberg; M Alfeie; E V Moor; R Caspi; H A Lipton; M R Wexler
Journal:  Ann Plast Surg       Date:  1995-06       Impact factor: 1.539

10.  Combination chemotherapy of metastatic malignant schwannoma with vincristine, adriamycin, cyclophosphamide, and imidazole carboxamide: a case report.

Authors:  R L Goldman; S E Jones; R S Heusinkveld
Journal:  Cancer       Date:  1977-05       Impact factor: 6.860

  10 in total
  2 in total

1.  Spinal cord metastasis of a non-neurofibromatosis type-1 malignant peripheral nerve sheath tumor: an unusual manifestation of a rare tumor.

Authors:  William S Baek; Peter Pytel; Samir D Undevia; Helene Rubeiz
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

Review 2.  Primary malignant peripheral nerve sheath tumour of the trachea: a case report and literature review.

Authors:  Yan Hu; Siying Ren; Wei Han; Boyou Zhang; Lu Shu; Yi Sun; Fenglei Yu; Wenliang Liu
Journal:  J Cardiothorac Surg       Date:  2020-09-11       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.